Cardiovascular disease remains a leading cause of morbidity and mortality in adults despite recent scientific advancements. Although people are living longer lives, there may be an adverse impact on ...

A major new study shows that giving heart attack patients a cholesterol-lowering combo treatment early on – not months later ...

Steve Stahl collapsed while skiing at Stowe from what is known as a "widowmaker," but survived that near-death experience thanks to a long list of caring Vermonters. At an emotional reunion, he ...

Camzyos’ failure in a form of hypertrophic cardiomyopathy dampened its commercial outlook and spurred debate as to whether ...

Bristol Myers Squibb's drug to treat a type of heart disease did not significantly improve functional capacity and symptoms ...

Bristol Myers Squibb stock skidded late Monday, tugging Cytokinetics lower, after Bristol's drug, Camzyos, failed in a heart disease study.

Patients who receive an add-on medication soon after a heart attack have a significantly better prognosis than those who receive it later, or not all, new research suggests.

The bloodied body of Sheerah Escudero's 18-year-old brother was found in 2017 with hands bound and head wrapped in packaging tape, a suspected victim of then-President Rodrigo Duterte's war on drugs ...

New Drug May Cut Sudden Heart Risk by 94% MONDAY, March 31, 2025 (HealthDay News) -- A new drug may help protect millions of people from heart attacks and strokes by lowering a little-known risk ...

Now, far fewer marathon runners who suffer cardiac arrest are dying of it. While more people than ever are running marathons in the U.S., the risk of dying from a heart attack during a run has ...

CHICAGO (Reuters) - The highest dose of an experimental drug developed by Eli Lilly significantly reduced levels of a genetically inherited risk factor for heart disease in a midstage trial, according ...